Biomarkers in frontotemporal dementia: Current landscape and future directions

Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration

Elisabeth H. Thijssen, Renaud La Joie, Amy Wolf et al. · Nature Medicine · 2020 · 767 citations · Full text

Frontotemporal Lobar Degeneration, Neurodegenerative Diseases, Alzheimer's Disease +13

Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study

Elisabeth H. Thijssen, Renaud La Joie, Amelia Strom et al. · The Lancet Neurology · 2021 · 538 citations · Full text

Frontotemporal Lobar Degeneration, Neurodegenerative Diseases, Alzheimer's Disease +14

Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis

Jonathan D. Rohrer, Jennifer Nicholas, David M. Cash et al. · The Lancet Neurology · 2015 · 531 citations · Full text

The epidemiology of frontotemporal dementia

Chiadi U. Onyike, Janine Diehl‐Schmid · International Review of Psychiatry · 2013 · 528 citations · Full text

Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia

Jonathan D. Rohrer, Ione Woollacott, Katrina M. Dick et al. · Neurology · 2016 · 440 citations · Full text